» Articles » PMID: 30391351

Clinical Presentation, Immunologic Features, and Hematopoietic Stem Cell Transplant Outcomes for IKBKB Immune Deficiency

Overview
Journal Clin Immunol
Date 2018 Nov 5
PMID 30391351
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

IKBKB immune deficiency is a rare but life-threatening primary immunodeficiency disorder, involving activation defects in adaptive and innate immunity. We present sixteen cases of a homozygous IKBKB mutation (c.1292dupG) in infants characterized by early-onset bacterial, viral, fungal and Mycobacterial infections. In most cases, T- and B-cells were quantitatively normal, but phenotypically naïve, with severe hypogammaglobulinemia. T-cell receptor excision circles were normal, meaning newborn screening by TREC analysis would miss IKBKB cases. Although IKBKB immune deficiency does not meet traditional laboratory based definitions for SCID, this combined immune deficiency appears to be at least as profound. Urgent HSCT, performed in eight patients, remains the only known curative therapy, although only three patients are survivors. Ongoing infections after transplant remain a concern, and may be due to combinations of poor social determinants of health, secondary graft failure, and failure of HSCT to replace non-hematopoietic cells important in immune function and dependent upon IKK/NF-κB pathways.

Citing Articles

Inborn errors of immunity in Canadian First Nations and Nunavut Inuit Children: the tip of the iceberg.

Pham-Huy A, Murguia-Favela L, Rubin T, Suresh S, Wright N, Derfalvi B Paediatr Child Health. 2025; 30(1):40-47.

PMID: 40061245 PMC: 11885879. DOI: 10.1093/pch/pxae026.


Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans.

Cildir G, Aba U, Pehlivan D, Tvorogov D, Warnock N, Ipsir C Nat Commun. 2024; 15(1):9944.

PMID: 39550372 PMC: 11569180. DOI: 10.1038/s41467-024-54345-4.


Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scan.

Mahon S, Reifferscheid L, Kenzie L, MacDonald S BMC Health Serv Res. 2024; 24(1):990.

PMID: 39187809 PMC: 11348588. DOI: 10.1186/s12913-024-11400-6.


Identification of steroid-induced osteonecrosis of the femoral head biomarkers based on immunization and animal experiments.

Luo D, Gao X, Zhu X, Wu J, Yang Q, Xu Y BMC Musculoskelet Disord. 2024; 25(1):596.

PMID: 39069636 PMC: 11285486. DOI: 10.1186/s12891-024-07707-4.


Mistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity.

Dabbah-Krancher G, Snow A Clin Exp Immunol. 2023; 212(2):117-128.

PMID: 36651621 PMC: 10128170. DOI: 10.1093/cei/uxad006.


References
1.
Mooster J, Le Bras S, Massaad M, Jabara H, Yoon J, Galand C . Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα. J Exp Med. 2015; 212(2):185-202. PMC: 4322042. DOI: 10.1084/jem.20140979. View

2.
Dupuis-Girod S, Cancrini C, Le Deist F, Palma P, Bodemer C, Puel A . Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics. 2006; 118(1):e205-11. DOI: 10.1542/peds.2005-2661. View

3.
Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M . A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest. 2003; 112(7):1108-15. PMC: 198529. DOI: 10.1172/JCI18714. View

4.
Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A . X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001; 27(3):277-85. DOI: 10.1038/85837. View

5.
Heimall J, Logan B, Cowan M, Notarangelo L, Griffith L, Puck J . Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017; 130(25):2718-2727. PMC: 5746165. DOI: 10.1182/blood-2017-05-781849. View